DR info

Clinical trials : 51 / Drugs : 53 - (DrugBank : 22) / Drug target genes : 32 - Drug target pathways : 67

Single Ventricle and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
210	Single Ventricle
46	Malignant rheumatoid arthritis
85	Idiopathic interstitial pneumonia
49	Systemic lupus erythematosus
2	Amyotrophic lateral sclerosis
86	Pulmonary arterial hypertension
51	Scleroderma
28	Systemic amyloidosis
266	Familial mediterranean fever
93	Primary biliary cholangitis
42	Polyarteritis nodosa
34	Neurofibromatosis
65	Primary immunodeficiency
299	Cystic fibrosis
331	Idiopathic multicentric castleman disease
57	Idiopathic dilated cardiomyopathy
113	Muscular dystrophy
6	Parkinson disease
56	Behcet disease
26	HTLV-1-associated myelopathy
96	Crohn disease
212	Tricuspid atresia
13	Multiple sclerosis/Neuromyelitis optica
169	Menkes disease
170	Occipital horn syndrome
58	Hypertrophic cardiomyopathy
22	Moyamoya disease
222	Primary nephrotic syndrome
70	Spinal stenosis
67	Polycystic kidney disease
11	Myasthenia gravis
118	Myelomeningocele
17	Multiple system atrophy
5	Progressive supranuclear palsy
337	Homocystinuria
139	Congenital cerebral hypomyelination
8	Huntington disease
288	Autoimmune acquired coagulation factor deficiency
211	Hypoplastic left heart syndrome
278	Huge lymphatic malformation with cervicofacial lesion
218	Alport syndrome
47	Buerger disease
88	Chronic thromboembolic pulmonary hypertension
225	Congenital nephrogenic diabetes insipidus
80	Resistance to thyroid hormone
78	Hypopituitarism
206	Fragile X syndrome
167	Marfan syndrome
251	Urea cycle disorder
111	Congenital myopathy